BBC

Fund Description
Virtus LifeSci Biotech Clinical Trials ETF is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the performance of the LifeSci Biotechnology Clinical Trials Index. Clinical Trials stage companies are typically younger, smaller companies which do not have a drug approved, but instead focus on testing their experimental drugs.
Fund Profile
Fund Name Virtus LifeSci Biotech Clinical Trials ETF
Fund Exchange Ticker BBC
Fund Sponsor Virtus ETF Solutions
Fund ISIN US26923G3011
Net Expense Ratio 0.79 %
Fund Inception Date 17 December 2014
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name LifeSci Biotechnology Clinical Trials Index
Index Provider LifeSci Index Partners
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 5 October 2022
Asset Under Management 18.08 Million (USD)
1 Month Total Return 4.79 %
Year To Date Return -32.90 %
1 Year Total Return -42.19 %
3 Year Annualized Total Return 3.27 %
NAV 25.8264
Share Outstanding 700,004
Top 10 Holdings (5 October 2022)
Constituent Name Constituent Ticker Constituent Type Weighting
AKERO THERAPEUTICS INC AKRO EQUI 0.0276000000
INHIBRX INC INBX EQUI 0.0202000000
Ventyx Biosciences Inc VTYX EQUI 0.0157000000
PROTHENA CORP PLC PRTA EQUI 0.0145000000
SERES THERAPEUTICS INC MCRB EQUI 0.0139000000
Prometheus Biosciences Inc RXDX EQUI 0.0138000000
MERSANA THERAPEUTICS INC MRSN EQUI 0.0137000000
KARUNA THERAPEUTICS INC KRTX EQUI 0.0137000000
IMMUNOVANT INC IMVT EQUI 0.0137000000
BNY MELLON CASH RESERVE USD MMKT 0.0127000000